Pedal arch patency, the challenge of critical limb ischemia

Original Title: Outcomes of Straight-Line Flow UIT and Without Pedal Arch in Patients UIT Critical Limb Ischemia. Reference: Akihiro Higashimori, et al. Catheterization and cardiovascular Intervention 2016;87:129-133

Courtesy of Dr. Carlos Fava.

Establishing one straight line flow into a patent pedal arch in critical limb ischemia is a real challenge occasionally achieved.

This study analyzed 137 patients with critical limb ischemia and only one vessel runoff to the foot; pedal arch patency was achieved in 76 patients vs. 61.

Baseline characteristics where similar, except for the presence of wounds, dialysis and heart failure, more frequent in the second group.

At one year, when patency was achieved, patients presented a higher amputation free survival rate (88.2% vs. 65.6%; p<0.01), more limb salvage (98.4% vs. 89.3%; p=0.03) and better healing.

Conclusion
Among patients with CLI where only one vessel runoff can be established to the foot, direct flow into a patent pedal arch is essential to improve their clinical outcomes.

Editorial Comment
Infrapopliteal intervention is complex and pedal arch revascularization takes long hours. We should be patient and aggressive to achieve optimal revascularization standards and reduce amputation rates.

The presence of heart failure, dialysis and wounds have a negative impact on outcomes.

The use of angiosomes to direct infrapopliteal angioplasty may help improve evolution, even though there are studies that do not share this viewpoint due to collateral circulation.

Courtesy of Dr. Carlos Fava.
Interventional Cardiologist
Favaloro Foundation – Buenos Aires

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...